NeoGenomics promotes Warren Stone to President & COO; Melody Harris to depart

NEOGENOMICS INC

Warren Stone promoted to President & COO effective April 1, 2025; previously CCO.
Stone's base salary increased to $650k, target bonus 70%, equity target $3M, plus incremental $1M equity.
Melody Harris to depart end of May 2025; her role as COO and President, Oncology Data Solutions eliminated.
Beth Eastland, SVP Enterprise Sales, to support Stone and assume day-to-day enterprise sales functions.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Warren Stone

President & Chief Operating Officer

NEO · NEOGENOMICS INC

Effective: 2025-04-01
Filed: March 19, 2025, 7:59 PM ET

On March 18, 2025, NeoGenomics, Inc. (the "Company") announced the promotion of Warren Stone, the Company's current Chief Commercial Officer, to the position of President & Chief Operating Officer, effective April 1, 2025.

Departed

Melody Harris

Chief Operations Officer and President, Oncology Data Solutions

NEO · NEOGENOMICS INC

Effective: 2025-04-01
Filed: March 19, 2025, 7:59 PM ET

Additionally, on March 18, 2025, the Company announced that the Chief Operations Officer and President, Oncology Data Solutions position is being eliminated and as a result, Melody Harris, the current Chief Operations Officer and President, Oncology Data Solutions will no longer hold such role effective April 1, 2025.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Warren Stone changed role as President & Chief Operating Officer at NEOGENOMICS INC.

Action: promoted
Role: President & Chief Operating Officer

Exact text from the filing

On March 18, 2025, NeoGenomics, Inc. (the "Company") announced the promotion of Warren Stone, the Company's current Chief Commercial Officer, to the position of President & Chief Operating Officer, effective April 1, 2025.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Melody Harris departed as Chief Operations Officer and President, Oncology Data Solutions at NEOGENOMICS INC.

Action: position eliminated
Role: Chief Operations Officer and President, Oncology Data Solutions

Exact text from the filing

Additionally, on March 18, 2025, the Company announced that the Chief Operations Officer and President, Oncology Data Solutions position is being eliminated and as a result, Melody Harris, the current Chief Operations Officer and President, Oncology Data Solutions will no longer hold such role effective April 1, 2025.

View on SEC.gov

NEOGENOMICS INC filing history →

Source: SEC EDGAR

accession 0001077183-25-000052

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.